Loading...

Commitment To Sustainability Strategies Will Drive Future Opportunities

Published
23 Mar 25
Updated
04 May 26
Views
123
04 May
€46.26
AnalystConsensusTarget's Fair Value
€72.50
36.2% undervalued intrinsic discount
Loading
1Y
-24.4%
7D
2.0%

Author's Valuation

€72.536.2% undervalued intrinsic discount

AnalystConsensusTarget Fair Value

Last Update 04 May 26

RF: Dividend And €200 Million Buyback Will Support Repricing Potential

Analysts have maintained their Eurazeo price target at €72.50, with only small model adjustments to discount rates, assumptions for long term revenue growth, and future P/E inputs supporting this unchanged view.

What's in the News

  • Eurazeo SE plans a Special and Extraordinary Shareholders Meeting on May 6, 2026, at 28 avenue George V, Paris, France. This may include key votes on governance or capital decisions (Key Developments).
  • Eurazeo SE is set to drop from the FTSE All-World Index (USD), which can affect how index funds and some institutional investors hold the stock (Key Developments).
  • A Board Meeting scheduled for March 10, 2026, is expected to consider and approve the renewal of the Richardson and Guyot Agreements and authorise Eurazeo to sign the 2026 Agreement (Key Developments).
  • Eurazeo SE announced an annual dividend of €2.92 per share, with ex-date on May 18, 2026, record date on May 19, 2026, and payment on May 20, 2026 (Key Developments).
  • The Board of Directors authorised a share buyback plan on March 11, 2026. This includes a share repurchase program of up to €200 million, valid until 2026 (Key Developments).

Valuation Changes

  • Fair Value: €72.50 remains unchanged, indicating no revision to the central valuation estimate.
  • Discount Rate: Increased slightly from 7.39% to about 7.43%, implying a marginally higher required return in the model.
  • Revenue Growth: Kept effectively stable at about 178.30%, with only a negligible technical adjustment in the model input.
  • Net Profit Margin: Held steady at roughly 51.60%, reflecting no meaningful change to long term profitability assumptions.
  • Future P/E: Adjusted slightly from 10.02x to about 10.03x, a very small change in the earnings multiple used in the model.
10 viewsusers have viewed this narrative update

Key Takeaways

  • Dynamic growth in asset management and improved operational efficiency suggest potential revenue and earnings growth.
  • Strong focus on shareholder returns and sustainable investment strategies could enhance EPS and capitalize on sustainability trends.
  • Legacy asset impacts and market uncertainties pose risks to earnings stability, asset values, and cash flow due to operational challenges and divestment strategies.

Catalysts

About Eurazeo
    A private equity and venture capital firm specializing in growth capital, series C, acquisitions, leveraged buyouts, and buy-ins of a private company, and investments in upper mid-market, mid-market and listed public companies, small- and mid-cap healthcare companies, equity in the small-mid and mid-large buyout segments.
What are the underlying business or industry changes driving this perspective?
  • Eurazeo's asset management segment is experiencing dynamic growth, with fundraising up 23% and management fees from third parties increasing by 14%. This suggests potential future revenue growth due to higher fee-paying assets under management (AUM).
  • The company is enhancing operational efficiency, as reflected by a 110 basis point improvement in its FRE margin to 35.5%, which is within its 35% to 40% medium-term target range. This improvement could positively impact net margins and earnings.
  • Asset rotation activity has picked up, with tripled exit volumes and doubled balance sheet realizations in 2024 compared to the previous year, leading to a 17% asset rotation with an average 10% upside. This could drive future earnings growth through realized gains on investments.
  • Eurazeo is committed to increasing shareholder returns via dividends and buybacks, with a planned 50% increase in 2025 relative to 2024. This could enhance earnings per share (EPS) and potentially attract more investment.
  • The expansion and success of Eurazeo's impact funds and sustainable investment strategies, such as the 40% target surpassing of Eurazeo's transition infrastructure fund, highlight opportunities for growth in sectors with increasing investor interest. This strategy supports revenue growth by capitalizing on sustainability trends.
Eurazeo Earnings and Revenue Growth

Eurazeo Future Earnings and Revenue Growth

Assumptions

How have these above catalysts been quantified?

  • Analysts are assuming Eurazeo's revenue will grow by 178.3% annually over the next 3 years.
  • Analysts assume that profit margins will increase from -944.8% today to 51.6% in 3 years time.
  • Analysts expect earnings to reach €475.0 million (and earnings per share of €8.36) by about May 2029, up from -€403.5 million today. However, there is a considerable amount of disagreement amongst the analysts with the most bullish expecting €829.7 million in earnings, and the most bearish expecting €291.5 million.
  • In order for the above numbers to justify the price target of the analysts, the company would need to trade at a PE ratio of 10.0x on those 2029 earnings, up from -7.1x today. This future PE is lower than the current PE for the GB Diversified Financial industry at 20.8x.
  • Analysts expect the number of shares outstanding to decline by 6.61% per year for the next 3 years.
  • To value all of this in today's terms, we will use a discount rate of 7.43%, as per the Simply Wall St company report.

Risks

What could happen that would invalidate this narrative?
  • The compression of valuation multiples for certain assets, such as WorldStrides, could signal a lower potential for revenue and earnings growth if these assets face operational or financial challenges.
  • The write-downs and negative impact from legacy assets like WorldStrides and 2RH indicate potential risks in the buyout portfolio that could affect future profitability and net margins.
  • The reliance on certain legacy strategies, such as U.S. consumer brands, which are being divested due to mixed performance, poses a risk to asset and earnings stability.
  • The substantial markdown of certain assets due to factors like COVID-19 impacts or liquidity covenants, particularly affecting companies with high leverage, could lead to earnings volatility and lower net asset values.
  • Market dependencies and macroeconomic uncertainties create execution risk in realizing asset exits, potentially impacting cash flows and net earnings if asset monetization does not proceed as anticipated.

Valuation

How have all the factors above been brought together to estimate a fair value?

  • The analysts have a consensus price target of €72.5 for Eurazeo based on their expectations of its future earnings growth, profit margins and other risk factors.
  • However, there is a degree of disagreement amongst analysts, with the most bullish reporting a price target of €85.0, and the most bearish reporting a price target of just €60.0.
  • In order for you to agree with the analysts, you'd need to believe that by 2029, revenues will be €920.5 million, earnings will come to €475.0 million, and it would be trading on a PE ratio of 10.0x, assuming you use a discount rate of 7.4%.
  • Given the current share price of €46.36, the analyst price target of €72.5 is 36.1% higher.
  • We always encourage you to reach your own conclusions though. So sense check these analyst numbers against your own assumptions and expectations based on your understanding of the business and what you believe is probable.

Have other thoughts on Eurazeo?

Create your own narrative on this stock, and estimate its Fair Value using our Valuator tool.

Create Narrative

How well do narratives help inform your perspective?

Disclaimer

AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.

Read more narratives